Centrum Medyczne Fundamenti
- Address
- Ul. Ks. Ignacego Skorupki 37a, 05-091 Ząbki, Poland
Centrum Medyczne Fundamenti Sp. z o.o.
Centrum Medyczne Fundamenti is a specialized research facility focused on post-acute sequelae of COVID-19 infection, particularly neurological and cognitive manifestations. The center employs advanced multimodal diagnostic approaches combining positron emission tomography (PET), biochemical, immunological, and electrophysiological assessments to understand complex post-viral syndromes.
- COVID-19 long-term neurological sequelae and cognitive dysfunction
- Brain fog pathophysiology using advanced neuroimaging techniques
- Pharmacological interventions for post-viral cognitive impairment
The center's research emphasizes comprehensive characterization of covid fog—a debilitating condition marked by slowed thinking, disorientation, memory difficulties, and impaired attention. Through the COVMENT trial, investigators evaluate tianeptine as a therapeutic intervention while simultaneously investigating the underlying pathophysiology through integrated neuropsychological, ENT, neurological, psychiatric, and advanced imaging assessments. This multidisciplinary approach positions the center at the forefront of understanding and treating post-COVID cognitive dysfunction.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Agencja Badań Medycznych1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centrum Medyczne Fundamenti
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety of Tianeptine Sodium in Treating Cognitive Dysfunction Post-COVID-19: A Randomized, Double-Blind, Placebo-Controlled Study | Agencja Badań Medycznych, Wojskowy Instytut Medyczny Panstwowy Instytut Badawczy | Phase II | Recruiting | Dec 2024 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Tianeptine Sodium | 1 | Unknown | 2024-12-02 | 2024-12-02 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.